Amilpar - Distribution of Interest on Capital Stock

RIO DE JANEIRO, Dec. 29 /PRNewswire-FirstCall/ -- Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managed care organization in Brazil, informs its Shareholders that the Board of Directors of the Company, in a meeting held today, approved the payment of Interest on Capital Stock in the gross amount of R$ 0.0168 per common share, corresponding to the total amount of R$ 6.0 million. The payment will be made on April 30, 2010, based on shareholders' position as of December 29, 2009.

Except for exempt shareholders under applicable legislation, the payment of Interest on Capital Stock will have deducted 15% (fifteen per cent) for Income Tax, resulting in net Interest of R$ 0.0143 per common share. The shareholders exempt from Tax Withholding must confirm this status by mailing the corresponding documents to the following address no later than January 5, 2010:

    Amilpar - Relacoes com Investidores (Investor Relations)
    Av. das Americas, 4,200 - Bl. 3 - 4th Floor - Barra da Tijuca
    Rio de Janeiro - RJ - Postal Code 22640-907

The Company will consider the shareholder not tax-exempt if the above- mentioned documents are not received by the aforementioned date.

The Interest on Capital Stock will be attributed to the minimum mandatory dividend relative to the fiscal year ending December 31, 2009 for its net amount, after the deduction of Income Tax, as per Paragraph 7, article 9 of the Brazilian Corporate Law # 9,249/95, and in item V of CVM Deliberation 207/96.

Please note that shares acquired on or after December 30, 2009 will be traded Ex-Interest on Capital Stock.

To access the Notice to Shareholders, visit our website at www.amilpar.com.br/ir

    IR Contact
    Erwin Kleuser
    Investor Relations Officer
    Phone: +55 (21) 3805-1155
    invest@amil.com.br
    www.amilpar.com.br/ir

SOURCE Amilpar

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.